News & Events Home Synthetic Biology The History of Synthetic Biology Living Medicines Designing Synthetic Biotics Pipeline + Programs Partner with Us Clinical Trials Our People Leadership Board of Directors Founders and Advisors Join Us Investors + Media Company Overview News & Events News Releases Events In the News Presentations & Publications Stock Information Stock Quote & Chart Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Board Diversity Matrix Financials Quarterly Results Investor Resources FAQs Contact IR Email Alerts RSS Feeds News Releases November 30, 2022 Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update November 10, 2022 Synlogic Reports Third Quarter 2022 Financial Results and Provides Business Update October 18, 2022 Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3 View All Upcoming Events There are currently no events to display. View All In the News FDA remains silent on orphan drug exclusivity after last year's court loss December 1, 2022 Source Endpoints News Seeking therapeutic opportunities amid the complexity of the microbiome November 24, 2022 Source Nature Phenylketonuria pipeline breaks into new modalities November 23, 2022 Source Biocentury View All Email Alerts Contact IR RSS Feeds Print Page Email Page
News Releases November 30, 2022 Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update November 10, 2022 Synlogic Reports Third Quarter 2022 Financial Results and Provides Business Update October 18, 2022 Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3 View All Upcoming Events There are currently no events to display. View All In the News FDA remains silent on orphan drug exclusivity after last year's court loss December 1, 2022 Source Endpoints News Seeking therapeutic opportunities amid the complexity of the microbiome November 24, 2022 Source Nature Phenylketonuria pipeline breaks into new modalities November 23, 2022 Source Biocentury View All
FDA remains silent on orphan drug exclusivity after last year's court loss December 1, 2022 Source Endpoints News
Seeking therapeutic opportunities amid the complexity of the microbiome November 24, 2022 Source Nature